Market Entry Sprint
Six to ten weeks. Single US category, single corridor. Scale claim rebuilt, US peer set named, outcome evidence translated, and the first wave of US-scale materials shipped into market.
See the Sprint →
Zurich firms optimised for cantonal or Swiss-national recognition arrive at a US market that expects category leadership at continent scale. The brand architecture that carried at home under-reads in the US peer set.
Zurich brand architecture is frequently optimised for cantonal-tier recognition, Zurich-metro standing, or Swiss-national presence. In Switzerland this is the right scale. A firm known across its canton, across several cantons, or across the Swiss national market holds a meaningful place in the home buyer's filter. The customer who recognises the name inherits trust from the home-market context. The brand's job is to register within the Swiss system, and inside that system the cantonal-tier or Swiss-national brand does what it was built to do.
The US market operates at a different scale by default. The American commercial buyer's first filter is a category filter, and the category filter is calibrated at continent scale. Who are the US-category leaders in this space. Who has the US installed base, the US customer coverage, the US plant footprint, the US clinical or commercial scale. The filter does not actively distinguish between a cantonal specialist and a national one, because neither signal enters the US scale reference frame. Both read as regional specialists of unclear category position.
The result is a predictable pattern. A Zurich firm that is materially strong at home brings the brand architecture that produced the home-market strength into US meetings. The US counterparty listens carefully and professionally and does not feel able to place the firm inside a US-scale category. The meeting is pleasant. The follow-up is slow. The internal conversation on the US side moves on to a firm whose scale claim indexes against the US filter cleanly. The Zurich firm's specialism, which was the strongest asset at home, became the scale-frame limitation in the US because it was presented as the brand's lead identity rather than as supporting proof inside a larger claim.
The cantonal-tier brand is not wrong. It is scaled for a different market. The US reader is not looking for the best firm in the canton. They are looking for the category leader at continent scale, and reading the brand for that signal first. House view on Zurich to US scale
The three break together. The scale claim, the peer set, and the outcome evidence all need to be reconstructed for a US-scale filter simultaneously.
The Swiss specialism becomes supporting proof inside a US-scale frame. The brand is not replaced. Its scale architecture is.
Six to ten weeks. Single US category, single corridor. Scale claim rebuilt, US peer set named, outcome evidence translated, and the first wave of US-scale materials shipped into market.
See the Sprint →Three to six months. Full US rebuild at US scale across positioning, site, sales materials, and conversion architecture. Standard shape for Zurich industrials and medtech committed to US scale.
See the Build →Monthly retainer, twelve-month minimum. Ongoing rebuild-and-run across multiple US-scale surfaces. Typical for Zurich family offices with several operating brands needing scale-frame rebuilds in parallel.
See the Partnership →No legal services. No Swiss company formation or US entity formation. No FINMA licensing, L-1, E-2, EB-5, or O-1 visa work. No US tax structuring, FATCA analysis, or double-tax-treaty review. No US banking introductions. No fiduciary services. No regulatory licensing. No IP filing. No contract drafting. No M&A advisory on US acquisitions.
These belong with Swiss counsel who specialise in US entry, and with US counsel on the American side. The firm works inside the parameters they set. When a marketing decision carries legal or tax implications, the firm flags it and defers before execution.
Zurich and Swiss-national brand architecture is optimised for a market where cantonal or national recognition is a high-trust signal. In a Swiss context, a firm known across the relevant canton or across Switzerland carries meaningful brand weight. The US market operates at a different scale. The American buyer's default filter expects a category leader at continent scale, with US customer references, US scale metrics, and US peer comparables. A canton-tier specialist brand, accurately presented, reads to the US buyer as a regional specialist of unclear relevance to the US category. The under-reading is not a content failure. It is a scale-frame mismatch built into the brand architecture itself.
No. Swiss specialism is a supporting proof asset. The correction changes what sits in front of it. The US-facing frame leads with a US-scale category claim: the US category the firm competes in, the US customer segment served, and the US outcome expected. Swiss specialism, cantonal-tier standing, and Swiss-national references then sit underneath as supporting evidence that the firm delivers reliably, not as the brand's lead identity. The home materials continue to lead with the cantonal or Swiss-national frame for the Swiss audience. The US surface is parallel, not replacement.
Industrials carry this most visibly because the US commercial buyer explicitly filters for scale: procurement volume, installed base, US plant footprint, and continent-scale service capability. Medtech and biotech follow: US payers, US health systems, and US biotech GPs filter on US clinical scale and US commercial scale. Engineering-commercial firms entering US enterprise accounts face the same filter at the commercial buyer level. Family-office-backed holdings carrying operating companies into US co-investment encounter it when US LPs apply scale screens to the portfolio.
No. Swiss company formation, FINMA licensing, US LLC or C-corp formation, L-1, E-2, EB-5, and O-1 visa support, transfer pricing, US tax residency, and US banking introductions are handled by Swiss counsel and US counsel. The firm designs US marketing architecture inside the structure counsel has already put in place. When a marketing decision carries legal or tax implications, the firm flags it and defers before execution.
Three steps in order. First, rebuild the scale claim: restate the firm at US-scale in the US category, with continent-scale reach, installed base, or customer coverage named in US-legible terms. Second, name the US peer set: which US-category leaders the firm competes alongside, what US customer segment it serves, and what US outcome benchmarks apply. Third, translate the outcome evidence out of a CHF or Swiss-national frame into US-legible metrics. Swiss specialism then carries as supporting proof inside a US-scale frame rather than as the dominant identity. The home-market cantonal or Swiss-national positioning continues at home.
The wider entry gate for Zurich principals, family offices, medtech, biotech, industrials, and engineering-commercial firms.
Back to the Zurich gate →The sibling problem. Swiss understatement reads at home as depth and in America as category absence. What the register translation looks like.
Read the sibling problem →Market Entry Sprint, Cross-Border Build, Group Partnership. The three routes through which the rebuild is delivered.
See the engagements →